Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Depreciation and Depletion (2021 - 2024)

Centessa Pharmaceuticals (CNTA) reported Depreciation and Depletion of $48000.0 for Q4 2024, down 47.83% year-over-year from $92000.0 in Q1 2024, and down 41.46% on a QoQ basis from $82000.0 in Q3 2024.

Centessa Pharmaceuticals (CNTA) has 4 years of Depreciation and Depletion data on file, last reported at $48000.0 in Q4 2024.

  • Quarterly Depreciation and Depletion fell 47.83% year-over-year to $48000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $300000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $300000.0, changed 0.0% from the prior year.
  • Depreciation and Depletion fell to $48000.0 in Q4 2024 per CNTA's latest filing, from $82000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $92000.0 in Q4 2023 and bottomed at $5434.0 in Q2 2021.
  • The 4-year median for Depreciation and Depletion is $42500.0 (2023), against an average of $53727.0.
  • The widest annual swing landed in 2022, when Depreciation and Depletion soared 488.88%; it then slumped 47.83% in 2024.
  • Tracing CNTA's Depreciation and Depletion over 4 years: stood at $15744.0 in 2021, then jumped by 128.66% to $36000.0 in 2022, then jumped by 155.56% to $92000.0 in 2023, then tumbled by 47.83% to $48000.0 in 2024.
  • Per Business Quant, the three latest CNTA Depreciation and Depletion figures stand at $48000.0 (Q4 2024), $82000.0 (Q3 2024), and $84000.0 (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1,395.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Centessa Pharmaceuticals 6.12 Bn 6.12 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 48,000.00
Dec 31, 2024 48,000.00
Sep 30, 2024 82,000.00
Sep 30, 2024 82,000.00
Jun 30, 2024 84,000.00
Jun 30, 2024 84,000.00
Mar 31, 2024 86,000.00
Mar 31, 2024 86,000.00
Dec 31, 2023 92,000.00
Dec 31, 2023 92,000.00
Sep 30, 2023 87,000.00
Sep 30, 2023 87,000.00
Jun 30, 2023 84,000.00
Jun 30, 2023 84,000.00
Mar 31, 2023 37,000.00
Mar 31, 2023 37,000.00
Dec 31, 2022 36,000.00
Dec 31, 2022 36,000.00
Sep 30, 2022 35,000.00
Sep 30, 2022 35,000.00
Jun 30, 2022 32,000.00
Jun 30, 2022 32,000.00
Mar 31, 2022 28,000.00
Mar 31, 2022 28,000.00
Sep 30, 2021 15,744.00
Sep 30, 2021 15,744.00
Jun 30, 2021 5,434.00
Jun 30, 2021 5,434.00